A Phase I Study of DVd +/ CC-5013 in Relapsed Refractory Multiple Myeloma (MM).
Phase of Trial: Phase I
Latest Information Update: 05 Dec 2016
At a glance
- Drugs Dexamethasone; Doxorubicin liposomal; Lenalidomide; Vincristine
- Indications Multiple myeloma
- Focus Adverse reactions
- 18 Aug 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 19 Dec 2006 Status change
- 23 Aug 2005 New trial record.